Enzo Biochem (NYSE:ENZ) soared 21% yesterday as its Ampiprobe SARS-CoV-2 Test System was granted Emergency Use Authorization by the FDA in a letter. The le
seekingalpha · 2天前
CLNE, NTES among premarket gainers
Seeking Alpha - Article · 2天前
Enzo Biochem's COVID test granted emergency authorization from the FDA
Seeking Alpha - Article · 2天前
Enzo Biochem to Provide COVID-19 Testing to Farmingdale State College Staff and Students as They Return to Campus
GlobeNewswire · 06/30 18:15
Should You Avoid Enzo Biochem, Inc. (ENZ)?
Insider Monkey · 06/25 22:50
Enzo Announces Issuance of U.S. Patent for Methods of Treating Liver Cancer Using Proprietary Compound SK1-I
GlobeNewswire · 06/23 13:30
Enzo Announces Issuance Of U.S. Patent for Methods Of Treating Liver Cancer Using Proprietary Compound SK1-I
Enzo Announces Issuance of U.S. Patent for Methods of Treating Liver Cancer Using Proprietary Compound SK1-I Continues to Explore Opportunities for Use of the Compound as a Potential Treatment for COVID-19 NEW YORK,
Benzinga · 06/23 12:31
Edited Transcript of ENZ earnings conference call or presentation 8-Jun-20 9:00pm GMT